Jlohr Brain Health
  • Home
  • About Us
  • Brain Health Diagnoses
  • Resources on this Site
    • Overviews: 9 Aspects of this Diagnoses
    • Drug Discount Services
    • With Each Diagnosis:
      • YouTube Video
      • Book from Library or Amazon
      • Support Group or Service
    • Tables for Patients:
      • Possible Special Education
      • Possible Social Security Disability Income
      • School Aid
    • Tables for Patients or Professionals
      • Overview of 9 Aspects of this Diagnosis
      • First Pages of Diagnoses from the Diagnostic and Statistical Manual and the Codes from the ICD-10 for Diagnosis and Compensation
  • Medical & Educational Downloads
  • Contact Us
Select Page

Clinical predictors and concomitant antiseizure medications effects on seizure control in relation to plasma cenobamate concentration: a multicenter retrospective study

by jlohrconsulting | Oct 8, 2025 | Uncategorized

Front Pharmacol. 2025 Sep 22;16:1668382. doi: 10.3389/fphar.2025.1668382. eCollection 2025. ABSTRACT INTRODUCTION: Cenobamate (CNB) is a novel antiseizure medication (ASM) approved as an add-on therapy for drug-resistant focal onset seizures. Although its mechanism of...

A Rare Case of Myopathy Associated with Entecavir Initiation

by jlohrconsulting | Oct 8, 2025 | Uncategorized

J Pharm Technol. 2025 Oct 5:87551225251382411. doi: 10.1177/87551225251382411. Online ahead of print. ABSTRACT Hepatitis B virus (HBV) infection can lead to severe complications, including cirrhosis, hepatocellular carcinoma, and death. Entecavir, a guanosine...

Impact of nano-selenium supplementation add-on sertraline on depressive symptoms and oxidative stress in patients with major depressive disorder: a triple-blind randomized controlled trial

by jlohrconsulting | Oct 8, 2025 | Uncategorized

Biometals. 2025 Oct 7. doi: 10.1007/s10534-025-00750-1. Online ahead of print. ABSTRACT Major depressive disorder (MDD) is a prevalent psychiatric condition associated with increased oxidative stress, which may contribute to its pathophysiology. Elevated...

Age differences in what-if thinking from midlife onwards: Prefrontal contribution and implications for emotional health in late life

by jlohrconsulting | Oct 8, 2025 | Uncategorized

Geroscience. 2025 Oct 7. doi: 10.1007/s11357-025-01928-8. Online ahead of print. ABSTRACT Reduced counterfactual (“What-If”) thinking (CFT) in late life is believed to reflect successful adaptation to limited resources for overcoming missed opportunities,...

Depressive Symptoms and Substance Use: Longitudinal Examination of Alcohol and Cannabis Coping Mechanisms in Young Adults

by jlohrconsulting | Oct 8, 2025 | Uncategorized

Prev Sci. 2025 Oct 8. doi: 10.1007/s11121-025-01846-3. Online ahead of print. ABSTRACT Depression and substance use are often comorbid, but less is known about these associations in non-clinical community samples. Moreover, existing research is primarily...
« Older Entries
Next Entries »

Recent Posts

  • Dissociative Drug-Induced Anxiety
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)

Recent Comments